Article
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
1 Jan 2021
Abstract excerpt
Cancer is a heterogeneous disease and its treatment remains unsatisfactory with inconstant therapeutic responses. This variability could be related, at least in part, to different and highly personalized gut microbiota compositions. Different studies have shown an impact of microbiota on antitumor therapy. It has been demonstrated that some gut bacteria influences the development and differentiation of immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
